Low-dose anti-thymocyte globulin plus low-dose post-transplant cyclophosphamide-based regimen for prevention of graft-versus-host disease after haploidentical peripheral blood stem cell transplants: a large sample, long-term follow-up retrospective study

IntroductionThe novel low-dose anti-thymocyte (ATG, 5 mg/kg) plus low-dose post-transplant cyclophosphamide (PTCy, 50 mg/kg) (low-dose ATG/PTCy)-based regimen had promising activity for prevention of graft-versus-host disease (GVHD) in haploidentical-peripheral blood stem cell transplantation (haplo...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Xingying Li, Jun Yang, Yu Cai, Chongmei Huang, Xiaowei Xu, Huiying Qiu, Jiahua Niu, Kun Zhou, Ying Zhang, Xinxin Xia, Yu Wei, Chang Shen, Yin Tong, Baoxia Dong, Liping Wan, Xianmin Song
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2023-10-01
Serija:	Frontiers in Immunology
Teme:	graft-versus-host disease haploidentical peripheral blood stem cell transplantation anti-thymocyte globulin cyclophosphamide
Online dostop:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1252879/full
Oznake:	Označite Brez oznak, prvi označite!